IGI receives CIRM CESCG CRP grant to study gene correction for SCD

The IGI has been awarded a CIRM grant to develop next-generation sequencing approaches to track gene correction in bone marrow stem cells for the treatment of sickle cell disease. The CIRM Center of Excellence in Stem Cell Genomics (CESCG) Collaborative Research Program (CRP) supports collaborative research projects by providing California scientists with access to cutting-edge genomics and bioinformatics technologies, and expertise and assistance in experimental design and data analysis. Working with CESCG, the IGI will determine how bone marrow stem cells respond to genetic engineering, characterize on- and off-target gene editing in these challenging cells, and work to move research on a gene editing cure for sickle cell disease closer to the clinic.

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

May 15, 2023

Welcome to Nicola

Nicola received his B.Sc in Biology from ETH Zürich in 2021. He is currently enrolled in the Molecular Health Sciences Master´s degree at ETH Zürich and joined...

April 21, 2023

Welcome to Naomi!

Naomi received her Bachelor’s degree in Health Science and Technology from ETH Zurich in 2021. Naomi joined the Corn lab in March 2023 as a Master student. For...

March 7, 2023

Congratulations to Mandy on the Innosuisse grant!

Mandy was awarded the Innosuisse Innovation grant to fund her translational work on developing gene therapies for hereditary blood diseases. This grant ...

News Archive

Tweets